Premium Reports
Population Health Management 2018, Part 1

Population Health Management 2018, Part 1
Partnering and Guidance the X Factors to PHM Success

Authored by: | Read Time: 6 minutes

When it comes to achieving success with population health management, good technology is not enough. Vendor partnering and guidance are the x factors provider organizations need to drive success with their value-based reimbursement (VBR) strategies. Some vendors have risen to the challenge, while others have faltered following acquisitions or efforts to scale. Whether organizations are looking to engage a vendor for a specific VBR strategy or for a more long-term approach, this report aims to help them uncover which vendors provide strong partnering and guidance to mitigate risk and help customers achieve positive financial and patient outcomes.

Want to see full details?

Key Findings

  1. Strong Partners: HealthEC Leads Out in PHM Partnership
  2. Weak Partners: Allscripts, athenahealth, and Philips Wellcentive Customers Often Left to Tackle PHM on Their Own
  3. HealthEC the Only Vendor to Excel at Strategic Guidance
  4. VBR Contract Guidance from HealthEC and Health Catalyst Helps Ensure Outcomes Are Achieved
  5. Product Optimization: Forward Health’s Training Leads to Optimized End-User Experience
  6. Vendors That Deliver on Both Partnering and Guidance Drive Highest Overall Satisfaction
  7. Acquisition and Functionality Issues Lead to Year-over-Year Declines for Some Vendors
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2019 KLAS Enterprises, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.